The BioNTech SE ADR BNTX advanced 2.40% to $122.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5,751.07 and the ...
European equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.23% to 1,417.34 on the S&P Europe Select ADR Index. For the week, the index is down about 1 ...
While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...
Company Conference Call October 1, 2024 9:00 AM ETCompany ParticipantsKarim Beguir - Chief Executive Officer, InstaDeepUÄŸur ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on BioNTech SE (BNTX – Research Report), with ...
In a report released today, Yaron Werber from TD Cowen maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price ...
This AI aims to facilitate interdisciplinary collaboration and uncover unexpected connections in scientific research.
Google DeepMind and BioNTech are building AI lab assistants to help researchers plan scientific experiments and better ...
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...
AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...